Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cancer genome sequencing provides the first direct information on how mutation rates vary across the human genome in somatic cells. Testing diverse genetic and epigenetic features, here we show that mutation rates in cancer genomes are strikingly related to chromatin organization. Indeed, at the megabase scale, a single feature—levels of the heterochromatin-associated histone modification H3K9me3—can account for more than 40% of mutation-rate variation, and a combination of features can account for more than 55%. The strong association between mutation rates and chromatin organization is upheld in samples from different tissues and for different mutation types. This suggests that the arrangement of the genome into heterochromatin- and euchromatin-like domains is a dominant influence on regional mutation-rate variation in human somatic cells.

Original publication




Journal article



Publication Date





504 - 507


Animals, CpG Islands, Epigenesis, Genetic, Euchromatin, Genome, Human, Heterochromatin, Histones, Humans, Leukemia, Lung Neoplasms, Male, Melanoma, Methylation, Mutagenesis, Mutation Rate, Neoplasms, Pan troglodytes, Polymorphism, Single Nucleotide, Principal Component Analysis, Prostatic Neoplasms, Small Cell Lung Carcinoma